Ed Reznik
- Molecular Biology top 5%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Biomedical Engineering
- Co-authors
- Chris SanderA. Ari HakimiSatish K. TickooDaniel SegrèWilliam LeeΕlad NoorBülent Arman AksoyRon Milo
- Topics
- Renal cell carcinoma treatment (23 papers)Cancer Genomics and Diagnostics (16 papers)Renal and related cancers (13 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Ed Reznik
57 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Molecular Biology 2.0k
- Cancer Research 988
- Pulmonary and Respiratory Medicine 681
- Oncology 283
- Biomedical Engineering 166
Countries citing papers authored by Ed Reznik
This map shows the geographic impact of Ed Reznik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Reznik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Reznik more than expected).
Fields of papers citing papers by Ed Reznik
This network shows the impact of papers produced by Ed Reznik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Reznik. The network helps show where Ed Reznik may publish in the future.
Co-authorship network of co-authors of Ed Reznik
This figure shows the co-authorship network connecting the top 25 collaborators of Ed Reznik. A scholar is included among the top collaborators of Ed Reznik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ed Reznik. Ed Reznik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 6 | |
| 6 | 1 | |
| 7 | 27 | |
| 8 | 5 | |
| 9 | 105 | |
| 10 | 17 | |
| 11 | 4 | |
| 12 | 58 | |
| 13 | 26 | |
| 14 | 44 | |
| 15 | 19 | |
| 16 | 23 | |
| 17 | 376 | |
| 18 | An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinomabreakdown → | 531 |
| 19 | 63 | |
| 20 | 1 |
About Ed Reznik
Ed Reznik is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 61 papers that have together received 2.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (23 papers), Cancer Genomics and Diagnostics (16 papers) and Renal and related cancers (13 papers). The work is most often cited by research in Cancer Research (988 citations), Molecular Biology (2.0k citations) and Pulmonary and Respiratory Medicine (681 citations). Ed Reznik has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Chris Sander, A. Ari Hakimi, Satish K. Tickoo, Daniel Segrè, William Lee, Εlad Noor, Bülent Arman Aksoy, Ron Milo, Martin L. Miller and Eric Minwei Liu. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.